Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 35; číslo 36; s. 3999
Hlavní autori:	Berchuck, Andrew, Secord, Angeles Alvarez, Moss, Haley A, Havrilesky, Laura J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 20.12.2017
Predmet:	Biomarkers, Tumor - genetics Clinical Decision-Making Cost-Benefit Analysis Drug Costs Female Genetic Predisposition to Disease Genetic Variation Humans Maintenance Chemotherapy Ovarian Neoplasms - drug therapy Ovarian Neoplasms - economics Ovarian Neoplasms - enzymology Ovarian Neoplasms - genetics Phenotype Poly(ADP-ribose) Polymerase Inhibitors - adverse effects Poly(ADP-ribose) Polymerase Inhibitors - economics Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use Precision Medicine - economics
ISSN:	1527-7755, 1527-7755
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Popis
Bibliografia:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1527-7755 1527-7755
DOI:	10.1200/JCO.2017.74.5752